Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen Sodium ER Actual Use Trial
NCT01427803Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aprol in pain, sponsored by Bayer. Started Sep 2011; status: completed.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on NCT01427803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01427803.